Printer Friendly
The Free Library
14,634,800 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

NJ court dismisses Vioxx medical monitoring suit.


The New Jersey Supreme Court ruled that Vioxx Vi·oxx

A trademark for the drug rofecoxib.


Vioxx® Rofecoxib Pain management A COX-2 inhibitor used to manage osteoarthritic pain, acute pain in adults, primary dysmenorrhea.
See COX-2 inhibitor.
 users who suffered no known harm from the withdrawn pain drug cannot sue Merck to pay for medical tests and treatment by heart doctors, Reuters reported June 4.

In the latest in a string of recent legal victories for Merck, the court agreed with a trial court that dismissed the medical monitoring suit in 2005. An appellate court A court having jurisdiction to review decisions of a trial-level or other lower court.

An unsuccessful party in a lawsuit must file an appeal with an appellate court in order to have the decision reviewed.
 later ruled that the original dismissal was premature.

Under the ruling, former Vioxx users will not be permitted to sue Merck to pay for electrocardiograms and follow-up consultations with cardiologists.

The 5-1 ruling by the state's highest court means a class-action lawsuit lawsuit: see procedure; tort.  by people who used the once-popular painkiller will be dismissed. One justice did not participate.

The lawsuit was filed by Vioxx users who claim they have no immediate symptoms but that use of the drug gives them a greater risk of developing illness. So they want diagnostic testing Diagnostic testing
Testing performed to determine if someone is affected with a particular disease.

Mentioned in: Von Willebrand Disease
 to uncover any hidden or developing problems. Because they aren't claiming they have an injury, they aren't eligible for the settlement Merck announced in November. Merck agreed to pay $4.85 billion to settle thousands of U.S. personal injury lawsuits involving a heart attack, stroke or death. Some 45,000 eligible claimants had initiated enrollment as of March 31.

The high court said that since the Vioxx users in the case don't claim injury, they "cannot satisfy the definition of harm" in seeking medical monitoring under the state's Product Liability Act.

In dissent An explicit disagreement by one or more judges with the decision of the majority on a case before them.

A dissent is often accompanied by a written dissenting opinion, and the terms dissent and dissenting opinion are used interchangeably.
, Justice Virginia A. Long argued that the law encompassed a broad definition of harm and includes the concept that an "increased risk of injury that creates a need for medical surveillance" is a recognizable harm.

Merck applauded the majority's decision. "The N.J. Supreme Court has made it clear that you cannot bring a

medical monitoring claim unless you allege To state, recite, assert, or charge the existence of particular facts in a Pleading or an indictment; to make an allegation.


allege v.
 you were injured in·jure  
tr.v. in·jured, in·jur·ing, in·jures
1. To cause physical harm to; hurt.

2. To cause damage to; impair.

3.
 by a product. The plaintiffs in this suit sought to recover from Merck even though Vioxx has been off the market for almost four years and they do not claim that it ever injured them," Merck lawyer Ted Mayer said in a statement.

The company also maintained there is no medical science supporting the plaintiffs' position that they need to be monitored for cardiovascular cardiovascular /car·dio·vas·cu·lar/ (-vas´ku-ler) pertaining to the heart and blood vessels.

car·di·o·vas·cu·lar
adj.
Abbr.
 conditions nearly four years later.

Merck pulled Vioxx from the market in September 2004 after its own study showed Vioxx doubles risk of heart attack or stroke.
COPYRIGHT 2008 Washington Information Source, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Litigation
Publication:Adverse Event Reporting News
Date:Jun 17, 2008
Words:404
Previous Article:Democrats preparing liability legislation.(Litigation)
Next Article:Merck faces expanded class in Canadian Vioxx lawsuit.(Litigation)
Topics:



Related Articles
New Cox-2 pain relievers are marketing marvel, not miracle drugs.
Judge lets Vioxx lawyers discuss FDA memo.(Food and Drug Administration )
New Jersey Court Affirms Nationwide Class in Vioxx Recoupment Litigation.(Case overview)
Merck wins.(Merck and Company Inc. wins a lawsuit filed by Stewart Grossberg on the adverse affects of the company's Vioxx)(Brief article)
Philadelphia Vioxx plaintiff drops suit; another plaintiff gets a second chance.(Litigation)
Merck will appeal verdict in NJ Vioxx case.(Litigation)(Merck and Company Inc.)(New Jersy, United States)
Plaintiff drops suit against Merck.(Litigation)(Brief article)
New Jersey high court denies class-action status to insurance companies in Vioxx cases.(Litigation)(Brief article)
Merck's strategy in Vioxx cases is working to limit liability.(Litigation)
Pfizer settles lawsuits over two painkillers.(Litigation)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles